Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M487Revenue $M153Net Margin (%)21.8Altman Z-Score2.0
Enterprise Value $M631EPS $0.7Operating Margin %29.0Piotroski F-Score4
P/E(ttm)14.4Beneish M-Score0.7Pre-tax Margin (%)28.5Higher ROA y-yY
Price/Book5.610-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsN
Price/Sales3.25-y EBITDA Growth Rate %--Current Ratio2.9Lower Leverage y-yN
Price/Free Cash Flow37.9y-y EBITDA Growth Rate %97.6ROA % (ttm)15.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)34.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M45.5ROIC % (ttm)57.5Gross Margin Increase y-yN

Gurus Latest Trades with SCMP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SCMPJoel Greenblatt 2015-12-31 Add0.08%$15.56 - $21.48
($17.91)
$ 10.69-40%Add 273.69%583,716
SCMPJoel Greenblatt 2015-09-30 Reduce-0.03%$16.34 - $28.96
($22.93)
$ 10.69-53%Reduce -53.28%156,205
SCMPJoel Greenblatt 2015-06-30 Add0.03%$14.5 - $21.75
($17.31)
$ 10.69-38%Add 222.92%334,346
SCMPJoel Greenblatt 2015-03-31 Buy 0.01%$13.12 - $18.56
($15.5)
$ 10.69-31%New holding103,538
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SCMP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SCMP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Smith Andrew PCFO 2015-11-16Buy1,605$17.03-37.23view
Getman Daniel PDirector 2015-08-28Sell30,000$28.14-62.01view
Knapp Thomas JFormer Officer 2015-07-20Sell64,528$23.43-54.37view
Kuno Sachiko10% Owner 2015-03-31Sell1,600,000$14-23.64view
S&R Technology Holdings, LLC10% Owner 2015-03-31Sell1,186,113$14-23.64view
Ueno Ryuji10% Owner 2015-03-31Sell1,600,000$14-23.64view
Ashton WilliamDirector 2015-03-12Sell129,766$17.42-38.63view
Celeste Anthony C.Director 2015-03-11Sell65,966$17.34-38.35view
Claiborne Cary JFormer Chief Financial Officer 2014-12-16Sell50,000$12.91-17.2view
S&R Technology Holdings, LLC10% Owner 2014-08-07Sell181,727$6.2870.22view

Quarterly/Annual Reports about SCMP:

News about SCMP:

Articles On GuruFocus.com
NeoPhotonics Delivers Sustained Profitability; Gevo Continues Biofuel Deal Momentum May 08 2015 
Pharmaceutical Stock Picks For March Mar 04 2015 
Weekly CEO Sells Highlight: VeriFone Systems Inc, Northeast Utilities, Sucampo Pharmaceuticals Inc, Jan 26 2014 
Weekly CEO Sells Highlight: Sucampo Pharmaceuticals Inc, Family Dollar Stores Inc, Nike Inc, Hallibu Oct 21 2013 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) May 10 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 06 2009 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 07 2009 

More From Other Websites
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Bank of America Merrill Lynch... May 03 2016
CORRECTING and REPLACING Sucampo Standardizes on Veeva Vault for a Single Source of Truth and... Apr 28 2016
Evolent Health awards executive bonuses following debut on NYSE Apr 21 2016
Evolent Health awards executive bonuses following debut on Nasdaq Apr 21 2016
Sucampo Announces First Quarter 2016 Earnings Call Apr 20 2016
Sucampo Announces First Quarter 2016 Earnings Call Apr 20 2016
Sucampo Pharma upgraded by Mizuho Apr 20 2016
Why These 5 Stocks Are Sinking Today Apr 19 2016
Sucampo declines 19.3% after early-stage trial misses primary endpoints Apr 19 2016
Sucampo Reports Top-Line Data from Phase 2a Study of Cobiprostone in Patients with PPI-Refractory... Apr 19 2016
4 Small Cap Stocks Trading with Low PEG Ratios Mar 31 2016
ETF’s with exposure to Sucampo Pharmaceuticals, Inc. : March 29, 2016 Mar 29 2016
SUCAMPO PHARMACEUTICALS, INC. Financials Mar 22 2016
ETF’s with exposure to Sucampo Pharmaceuticals, Inc. : March 14, 2016 Mar 14 2016
Sucampo Pharmaceuticals, Inc. :SCMP-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 14 2016
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report Mar 11 2016
Sucampo (SCMP) Stock Plunges Despite Strong Q4 Results Mar 09 2016
Sucampo Beats Earnings & Revenues on Strong Amitiza Sales Mar 09 2016
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 28th Annual ROTH Conference Mar 09 2016
Sucampo Q4 Beats Estimates, Affirms Guidance, Driving Up Stock Mar 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)